Eiger BioPharmaceuticals
company
Funding Round
Post-IPO Equity
Money Raised
$ 5M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Innovatus Capital Partners | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Feb 25, 2009 | Series A | $ 8.30M | InterWest Partners,Vivo Capital | Detail |
| Nov 23, 2015 | Debt Financing | $ 6M | Detail | |
| Apr 15, 2011 | Series A | $ 14.46M | InterWest Partners,Vivo Capital | Detail |
| Oct 26, 2017 | Post-IPO Equity | $ 19.50M | Detail | |
| Jan 1, 2007 | Seed | 0 | RA Capital Management | Detail |
| Jan 4, 2017 | Post-IPO Debt | $ 25M | Oxford Finance LLC | Detail |
| Apr 29, 2016 | Post-IPO Equity | $ 2.99M | Detail | |
| Mar 21, 2016 | Debt Financing | 0 | InterWest Partners | Detail |
| Mar 23, 2016 | IPO | 0 | Detail |
